Researchers use DNA sequencing method to detect blood pathogens

10/14/2011 | BioOptics World

Use of a DNA sequencing method called peptide nucleic acid fluorescence in-situ hybridization in ICU patients with enterococcus or streptococcus bloodstream infections reduced their mortality rate by nearly 50% and cut mortality from yeast infections by 86%, according to a study conducted by researchers at the University of Arizona. The method also led to reductions in health care costs by about $5 million annually, the researchers said.

View Full Article in:

BioOptics World

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT